Biotest AG logo

BIO3 - Biotest AG News Story

€29.6 -0.2  -0.7%

Last Trade - 13/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.02bn
Enterprise Value £1.35bn
Revenue £419.7m
Position in Universe 387th / 1046

BRIEF-Biotest: Trimodulin Concept For Phase III Study Coordinated With The Authorities

Wed 20th December, 2017 6:00am
Dec 20 (Reuters) - BIOTEST AG  BIOG.DE : 
    * DGAP-NEWS: BIOTEST AG: TRIMODULIN: CONCEPT FOR PHASE III STUDY SUCCESSFULLY COORDINATED 
WITH THE 
AUTHORITIES 
 
Source text for Eikon:  ID:nEQ5kpj3pa  
Further company coverage:  BIOG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.